IBEX Technologies Inc. Logo

IBEX Technologies Inc.

IBXNF

(3.2)
Stock Price

1,00 USD

11.85% ROA

32.31% ROE

20.48x PER

Market Cap.

28.213.001,31 USD

13.31% DER

0% Yield

51.62% NPM

IBEX Technologies Inc. Stock Analysis

IBEX Technologies Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

IBEX Technologies Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (16.2%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

3 DER

The stock has a minimal amount of debt (13%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Revenue Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

5 Assets Growth

With a track record of consistent revenue growth in the past five years, this company presents a compelling opportunity.

6 PBV

The stock's PBV ratio (2.5x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

7 Net Profit Growth

Over the last three years, this company has consistently achieved net profit growth, indicating a favorable financial performance and making it an attractive investment option.

8 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (4), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

9 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

10 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

11 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

IBEX Technologies Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

IBEX Technologies Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

IBEX Technologies Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

IBEX Technologies Inc. Revenue
Year Revenue Growth
1995 4.500.000
1996 1.600.000 -181.25%
1997 900.000 -77.78%
1998 900.000 0%
1999 900.000 0%
2000 1.048.364 14.15%
2001 863.000 -21.48%
2002 762.266 -13.22%
2003 1.815.103 58%
2004 1.623.956 -11.77%
2005 1.893.353 14.23%
2006 2.091.888 9.49%
2007 2.023.624 -3.37%
2008 2.326.744 13.03%
2009 3.544.282 34.35%
2010 2.628.746 -34.83%
2011 2.243.902 -17.15%
2012 2.924.700 23.28%
2013 3.968.829 26.31%
2014 3.943.144 -0.65%
2015 3.491.130 -12.95%
2016 4.113.694 15.13%
2017 5.326.721 22.77%
2018 4.729.599 -12.63%
2019 4.308.320 -9.78%
2020 5.209.809 17.3%
2021 5.306.187 1.82%
2022 7.892.487 32.77%
2023 9.056.784 12.86%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

IBEX Technologies Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1995 7.600.000
1996 4.300.000 -76.74%
1997 4.800.000 10.42%
1998 12.200.000 60.66%
1999 7.300.000 -67.12%
2000 2.408.842 -203.05%
2001 1.689.000 -42.62%
2002 265.312 -536.61%
2003 815.305 67.46%
2004 2.183.042 62.65%
2005 2.203.385 0.92%
2006 2.263.061 2.64%
2007 1.254.883 -80.34%
2008 -76.548 1739.34%
2009 0 0%
2010 42.367 100%
2011 259.837 83.69%
2012 245.752 -5.73%
2013 368.914 33.39%
2014 383.492 3.8%
2015 436.434 12.13%
2016 268.085 -62.8%
2017 201.871 -32.8%
2018 247.683 18.5%
2019 304.121 18.56%
2020 121.385 -150.54%
2021 141.562 14.25%
2022 347.403 59.25%
2023 477.828 27.3%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

IBEX Technologies Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1995 0
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

IBEX Technologies Inc. EBITDA
Year EBITDA Growth
1995 -6.300.000
1996 -5.800.000 -8.62%
1997 -6.800.000 14.71%
1998 -14.600.000 53.42%
1999 -9.500.000 -53.68%
2000 -3.451.331 -175.26%
2001 -2.424.000 -42.38%
2002 -1.280.442 -89.31%
2003 -2.136.761 40.08%
2004 -2.653.288 19.47%
2005 -3.648.223 27.27%
2006 -2.484.749 -46.82%
2007 -2.206.746 -12.6%
2008 306.256 820.56%
2009 1.445.454 78.81%
2010 648.929 -122.74%
2011 274.171 -136.69%
2012 381.102 28.06%
2013 54.575 -598.31%
2014 -226.201 124.13%
2015 -188.298 -20.13%
2016 423.291 144.48%
2017 880.356 51.92%
2018 202.430 -334.89%
2019 -682.863 129.64%
2020 1.071.555 163.73%
2021 1.530.918 30.01%
2022 2.775.269 44.84%
2023 3.183.996 12.84%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

IBEX Technologies Inc. Gross Profit
Year Gross Profit Growth
1995 1.300.000
1996 1.300.000 0%
1997 900.000 -44.44%
1998 900.000 0%
1999 900.000 0%
2000 1.048.364 14.15%
2001 863.000 -21.48%
2002 762.266 -13.22%
2003 1.815.103 58%
2004 1.623.956 -11.77%
2005 1.893.353 14.23%
2006 2.091.888 9.49%
2007 2.023.624 -3.37%
2008 2.326.744 13.03%
2009 3.544.282 34.35%
2010 2.628.746 -34.83%
2011 2.243.902 -17.15%
2012 1.663.245 -34.91%
2013 2.037.446 18.37%
2014 1.847.144 -10.3%
2015 1.617.540 -14.19%
2016 2.063.218 21.6%
2017 2.927.712 29.53%
2018 1.804.204 -62.27%
2019 1.358.888 -32.77%
2020 2.968.888 54.23%
2021 3.033.970 2.15%
2022 5.358.203 43.38%
2023 6.664.924 19.61%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

IBEX Technologies Inc. Net Profit
Year Net Profit Growth
1995 8.600.000
1996 -8.500.000 201.18%
1997 -6.100.000 -39.34%
1998 -14.100.000 56.74%
1999 -9.100.000 -54.95%
2000 -3.289.828 -176.61%
2001 -2.255.000 -45.89%
2002 10.308.158 121.88%
2003 -310.818 3416.46%
2004 -2.892.261 89.25%
2005 -3.978.403 27.3%
2006 -2.880.372 -38.12%
2007 -7.409.662 61.13%
2008 348.319 2227.26%
2009 1.343.738 74.08%
2010 506.362 -165.37%
2011 103.602 -388.76%
2012 229.981 54.95%
2013 40.416 -469.03%
2014 -480.734 108.41%
2015 209.628 329.33%
2016 100.560 -108.46%
2017 2.981.839 96.63%
2018 -95.189 3232.55%
2019 -1.267.682 92.49%
2020 965.689 231.27%
2021 761.503 -26.81%
2022 1.674.395 54.52%
2023 3.565.724 53.04%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

IBEX Technologies Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1995 2
1996 -1 0%
1997 0 0%
1998 -1 0%
1999 -1 0%
2000 0 0%
2001 0 0%
2002 1 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

IBEX Technologies Inc. Free Cashflow
Year Free Cashflow Growth
1995 94.500.000
1996 -51.000.000 285.29%
1997 -6.500.000 -684.62%
1998 -12.700.000 48.82%
1999 -10.400.000 -22.12%
2000 419.309 2580.27%
2001 -259.000 261.9%
2002 -1.233.167 79%
2003 -3.072.411 59.86%
2004 -2.787.876 -10.21%
2005 -3.883.983 28.22%
2006 -2.488.495 -56.08%
2007 -2.042.516 -21.83%
2008 80.595 2634.3%
2009 673.631 88.04%
2010 771.389 12.67%
2011 -820.254 194.04%
2012 458.991 278.71%
2013 -71.127 745.31%
2014 120.777 158.89%
2015 438.446 72.45%
2016 861.817 49.13%
2017 153.810 -460.31%
2018 178.246 13.71%
2019 -519.300 134.32%
2020 1.266.320 141.01%
2021 937.525 -35.07%
2022 3.435.944 72.71%
2023 102.440 -3254.1%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

IBEX Technologies Inc. Operating Cashflow
Year Operating Cashflow Growth
1995 95.100.000
1996 -50.700.000 287.57%
1997 -5.900.000 -759.32%
1998 -12.300.000 52.03%
1999 -10.300.000 -19.42%
2000 509.837 2120.25%
2001 -76.000 770.84%
2002 -1.170.049 93.5%
2003 -2.804.929 58.29%
2004 -2.375.431 -18.08%
2005 -3.759.943 36.82%
2006 -2.235.714 -68.18%
2007 -2.033.944 -9.92%
2008 86.281 2457.35%
2009 1.049.176 91.78%
2010 1.159.457 9.51%
2011 -358.634 423.3%
2012 468.476 176.55%
2013 318.916 -46.9%
2014 174.386 -82.88%
2015 452.746 61.48%
2016 923.466 50.97%
2017 1.074.925 14.09%
2018 215.966 -397.73%
2019 -453.565 147.62%
2020 1.368.250 133.15%
2021 1.208.697 -13.2%
2022 3.580.785 66.24%
2023 180.563 -1883.12%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

IBEX Technologies Inc. Capital Expenditure
Year Capital Expenditure Growth
1995 600.000
1996 300.000 -100%
1997 600.000 50%
1998 400.000 -50%
1999 100.000 -300%
2000 90.528 -10.46%
2001 183.000 50.53%
2002 63.118 -189.93%
2003 267.482 76.4%
2004 412.445 35.15%
2005 124.040 -232.51%
2006 252.781 50.93%
2007 8.572 -2848.92%
2008 5.686 -50.76%
2009 375.545 98.49%
2010 388.068 3.23%
2011 461.620 15.93%
2012 9.485 -4766.84%
2013 390.043 97.57%
2014 53.609 -627.57%
2015 14.300 -274.89%
2016 61.649 76.8%
2017 921.115 93.31%
2018 37.720 -2341.98%
2019 65.735 42.62%
2020 101.930 35.51%
2021 271.172 62.41%
2022 144.841 -87.22%
2023 78.123 -85.4%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

IBEX Technologies Inc. Equity
Year Equity Growth
1995 6.400.000
1996 26.400.000 75.76%
1997 24.200.000 -9.09%
1998 21.200.000 -14.15%
1999 12.100.000 -75.21%
2000 8.809.372 -37.35%
2001 6.555.000 -34.39%
2002 17.788.156 63.15%
2003 17.773.548 -0.08%
2004 15.181.247 -17.08%
2005 11.695.671 -29.8%
2006 8.876.586 -31.76%
2007 1.706.592 -420.14%
2008 2.071.301 17.61%
2009 3.420.340 39.44%
2010 4.047.909 15.5%
2011 4.192.504 3.45%
2012 4.422.485 5.2%
2013 4.535.157 2.48%
2014 4.172.794 -8.68%
2015 4.671.762 10.68%
2016 4.778.741 2.24%
2017 7.753.669 38.37%
2018 7.789.753 0.46%
2019 6.573.772 -18.5%
2020 7.119.680 7.67%
2021 7.901.732 9.9%
2022 9.747.118 18.93%
2023 11.407.200 14.55%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

IBEX Technologies Inc. Assets
Year Assets Growth
1995 56.100.000
1996 29.100.000 -92.78%
1997 26.500.000 -9.81%
1998 25.100.000 -5.58%
1999 14.200.000 -76.76%
2000 9.674.972 -46.77%
2001 7.624.000 -26.9%
2002 20.417.701 62.66%
2003 19.911.995 -2.54%
2004 16.706.713 -19.19%
2005 13.195.881 -26.61%
2006 10.100.419 -30.65%
2007 2.551.603 -295.85%
2008 2.526.655 -0.99%
2009 4.181.548 39.58%
2010 4.519.951 7.49%
2011 4.479.291 -0.91%
2012 4.776.087 6.21%
2013 6.379.812 25.14%
2014 5.776.031 -10.45%
2015 6.379.167 9.45%
2016 6.442.583 0.98%
2017 9.534.763 32.43%
2018 9.446.623 -0.93%
2019 8.386.724 -12.64%
2020 8.593.215 2.4%
2021 9.458.220 9.15%
2022 12.974.197 27.1%
2023 14.090.065 7.92%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

IBEX Technologies Inc. Liabilities
Year Liabilities Growth
1995 49.700.000
1996 2.700.000 -1740.74%
1997 2.300.000 -17.39%
1998 3.900.000 41.03%
1999 2.100.000 -85.71%
2000 865.600 -142.61%
2001 1.069.000 19.03%
2002 2.629.545 59.35%
2003 2.138.447 -22.97%
2004 1.525.466 -40.18%
2005 1.500.210 -1.68%
2006 1.223.833 -22.58%
2007 845.011 -44.83%
2008 455.354 -85.57%
2009 761.208 40.18%
2010 472.042 -61.26%
2011 286.787 -64.6%
2012 353.602 18.9%
2013 1.844.655 80.83%
2014 1.603.237 -15.06%
2015 1.707.405 6.1%
2016 1.663.842 -2.62%
2017 1.781.094 6.58%
2018 1.656.870 -7.5%
2019 1.812.952 8.61%
2020 1.473.535 -23.03%
2021 1.556.488 5.33%
2022 3.227.079 51.77%
2023 2.682.865 -20.28%

IBEX Technologies Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.19
Net Income per Share
0.06
Price to Earning Ratio
20.48x
Price To Sales Ratio
4.92x
POCF Ratio
44.3
PFCF Ratio
254.24
Price to Book Ratio
3
EV to Sales
3.87
EV Over EBITDA
12.11
EV to Operating CashFlow
28.77
EV to FreeCashFlow
200.17
Earnings Yield
0.05
FreeCashFlow Yield
0
Market Cap
0,03 Bil.
Enterprise Value
0,02 Bil.
Graham Number
0.7
Graham NetNet
0.21

Income Statement Metrics

Net Income per Share
0.06
Income Quality
0.46
ROE
0.15
Return On Assets
0.23
Return On Capital Employed
-0.09
Net Income per EBT
1.87
EBT Per Ebit
-1.5
Ebit per Revenue
-0.18
Effective Tax Rate
-0.84

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.09
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.71
Operating Profit Margin
-0.18
Pretax Profit Margin
0.28
Net Profit Margin
0.52

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.03
Free CashFlow per Share
0
Capex to Operating CashFlow
-0.86
Capex to Revenue
-0.12
Capex to Depreciation
-2.1
Return on Invested Capital
0.09
Return on Tangible Assets
0.12
Days Sales Outstanding
116.18
Days Payables Outstanding
250.98
Days of Inventory on Hand
52.56
Receivables Turnover
3.14
Payables Turnover
1.45
Inventory Turnover
6.94
Capex per Share
-0.02

Balance Sheet

Cash per Share
0,25
Book Value per Share
0,38
Tangible Book Value per Share
0.38
Shareholders Equity per Share
0.38
Interest Debt per Share
0.05
Debt to Equity
0.13
Debt to Assets
0.11
Net Debt to EBITDA
-3.27
Current Ratio
7.13
Tangible Asset Value
0,01 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
0.13
Working Capital
0,01 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
229193
Debt to Market Cap
0.05

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

IBEX Technologies Inc. Dividends
Year Dividends Growth

IBEX Technologies Inc. Profile

About IBEX Technologies Inc.

IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.

CEO
Mr. Paul Baehr
Employee
0
Address
5485 Rue Pare
Montreal, H4P 1P7

IBEX Technologies Inc. Executives & BODs

IBEX Technologies Inc. Executives & BODs
# Name Age
1 Mr. Mahendra Kumar Pallapothu
Vice President of Operations
70
2 Mr. Paul Baehr
President, Chief Executive Officer & Chairman
70
3 Belinda Franco C.A., CPA
Chief Financial Officer, Vice President of Finance & Administration and Secretary
70

IBEX Technologies Inc. Competitors